SYSTEMS AND METHODS FOR DETECTING HEALTH DISORDERS

• US 20130324868A1
• Filed: 05/31/2013
• Published: 12/05/2013
• Est. Priority Date: 05/31/2012
• Status: Active Grant

• Current Assignee: Zoll Medical Corporation (Asahi Kasei Corporation)
• Original Assignee: Zoll Medical Corporation (Asahi Kasei Corporation)
• Inventors: Kaib, Thomas E., Volpe, Shane S., Whiting, Jason T., Frank, Gregory R., Carlson, Rachel H.
• Granted Patent: US 9,814,894 B2
• Time in Patent Office: Days
• US Class Current: 600/510
• CPC Class Codes: A61B 5/1113 Local tracking of patients, e.g. in a hospital or private home
• CPC Class Codes: A61B 5/1118 Determining activity level
• CPC Class Codes: A61B 5/318 Heart-related electrical modalities, e.g. electrocardiography [ECG]
• CPC Class Codes: A61B 5/48 Other medical applications
• CPC Class Codes: A61N 1/3937 Monitoring output parameters

Abstract

According to some embodiments, a wearable medical device capable of treating a patient presenting with syncope is provided. The wearable medical device includes a memory storing event profile information, a battery, at least one treatment electrode coupled to the battery, at least one processor coupled to the memory and the at least one treatment electrode, and an event manager executed by the at least one processor. The event manager is configured to detect an event associated with syncope; store, in the memory, data descriptive of the event in association with an indication that the data includes data descriptive of a syncopal event; and address the to event.

Claims

1. A method of treating a patient presenting with syncope, the method comprising:

detecting, by a wearable defibrillator, an event associated with syncope;

storing, by the wearable defibrillator, data descriptive of the event in association with an indication that the data includes data descriptive of a syncopal event; and

addressing the event.

2. The method according to claim 1, wherein detecting the event includes detecting a to cardiac arrhythmia.

3. The method according to claim 2, wherein detecting the cardiac arrhythmia includes detecting at least one of ventricular tachycardia, ventricular fibrillation, and bradycardia and addressing the event includes issuing a therapeutic treatment.

4. The method according to claim 3, wherein issuing the therapeutic treatment includes issuing at least one of a pacing pulse and a defibrillation shock.

5. The method according to claim 1, wherein addressing the event includes issuing a notification to an external entity.

6. The method according to claim 1, wherein detecting the event includes identifying a pattern of data including data received from a plurality of sensors.

7. The method according to claim 6, wherein identifying the pattern of data includes identifying a pattern of data that includes data received from at least one of an electrocardiogram sensor, a motion sensor, and an optical sensor.

8. The method according to claim 7, wherein identifying the pattern of data includes identifying a pattern of data indicative of a level of dyskinesia.

9. The method according to claim 8, wherein identifying the pattern of data includes identifying a pattern of data indicative of a location of a patient within a space.

10. A wearable medical device capable of treating a patient presenting with syncope, the wearable medical device comprising:

a memory storing event profile information;

a battery;

at least one treatment electrode coupled to the battery;

at least one processor coupled to the memory and the at least one treatment to electrode; and

an event manager executed by the at least one processor and configured to;

detect an event associated with syncope;

store, in the memory, data descriptive of the event in association with an indication that the data includes data descriptive of a syncopal event; and

address the event.

11. The device according to claim 10, wherein the event includes a cardiac arrhythmia.

12. The device according to claim 11, wherein the cardiac arrhythmia is at least one of ventricular tachycardia, ventricular fibrillation, and bradycardia and the event manager is configured to address the event by issuing a therapeutic treatment.

13. The device according to claim 12, wherein the event manager is configured to issue the therapeutic treatment by issuing at least one of a pacing pulse and a defibrillation shock.

14. The device according to claim 10, wherein the event manager is configured to address the event by issuing a notification to an external entity.

15. The device according to claim 10, wherein the event manager is configured to detect the event by identifying a pattern of data including data received from a plurality of sensors.

16. The device according to claim 15, wherein the event manager is configured to identify the pattern of data by identifying a pattern of data that includes data received from at least one of an electrocardiogram sensor and a motion sensor.

17. The device according to claim 16, wherein the event profile information includes to information descriptive of the pattern of data.

18. The method according to claim 17, wherein the pattern of data includes a pattern of data indicative of a level of dyskinesia.

19. The method according to claim 18, wherein the pattern of data includes a pattern of data indicative of a location of a patient within a space.

20. A method for protecting a patient presenting with syncope from cardiac dysfunction, the method comprising:

identifying a syncopal event within the patient'"'"'s history; and

providing, responsive to identifying the syncopal event, the patient with a wearable defibrillator.

21. The method according to claim 20, further comprising monitoring the patient'"'"'s physiology via the wearable defibrillator.

22. The method according to claim 21, further comprising contacting the patient where monitoring reveals the presence of an arrhythmia.

23. The method according to claim 22, wherein the act of providing the patient with the wearable defibrillator is responsive to a diagnosis of at least one of cardiac dysfunction and undiagnosed syncope.

24. The method according to claim 20, wherein the act of providing the patient with the wearable defibrillator includes providing the patient with a wearable defibrillator configured to identify and treat cardiac dysfunction.

25. The method according to claim 20, wherein the act of providing the patient with to the wearable defibrillator includes an act of providing the patient with a wearable defibrillator that includes a long term wear electrode.